I
s the higher reported colorectal cancer (CRC) mortality in blacks versus whites in the United States due to pathology or disparities in screening? Our study used patient navigation (PN) to facilitate blacks' and whites' adherence to screening colonoscopy and compared adenomas detected in each group.
Methods
The National Colonoscopy Study is a multicenter, randomized trial of screening colonoscopy versus annual guaiac fecal occult blood testing in average-risk people 40-69 years of age. This analysis reports those undergoing colonoscopy at Louisiana State University (LSU) Health Sciences Center Shreveport, a predominantly underserved minority population. The study was approved by the LSU Institutional Review Board. Pathology was reviewed by 1 pathologist. PN aided in scheduling, recognizing logistical and financial barriers, and colonoscopy preparation. Both groups (blacks and whites) had PN assistance. Data included adherence to screening, withdrawal time, cecal intubation, and bowel preparation adequacy. Polyp data included size, location, number, shape, and pathology. Colonoscopy outcome was defined by the most advanced polyp type for each patient.
A Poisson model with robust error variances was used to estimate the relative risk for blacks' and whites' adherence to colonoscopy and prevalence of any adenoma or advanced adenoma compared to no polyps. The relative risks for any adenoma or advanced adenoma were also adjusted for age, sex, education, smoking, nonsteroidal anti-inflammatory drug use and obesity. Statistical analysis was performed using SAS version 9.2 (SAS Institute, Cary, NC).
Results
There were 1,008 patients enrolled: 504 were randomized to screening colonoscopy; 246 (50.6%) were black, 240 were (49.4%) white, and 18 were "other" and excluded. Groups were comparable in age (52.3 years of age for blacks, 53.2 years of age for whites) and sex (68% female blacks, 61% female whites) but not in level of education (higher in whites). Adherence to colonoscopy for blacks (78%) and whites (83%) was comparable (relative risk, 0.94; 95% confidence interval, 0.86-1.02) as well as with adjustment for age, sex, and education (relative risk, 1.03, 95%
Abbreviations used in this paper: CRC, colorectal cancer; LSU, Louisiana State University; PN, patient navigation. confidence interval, 0.96-1.11) ( Table 1 ). Quality of colonoscopy (measured by cecal intubation rate, adequate bowel preparation, and mean withdrawal time) was comparable for blacks and whites. Patients with any adenomas and advanced adenomas were similar for blacks and whites (Table 1) , as well as for nonadvanced adenomas (18% and 21%, respectively). No CRCs were detected. Age was a significant predictor of adenomas but risk for adenomas did not differ for blacks and whites by age group. Overall, the distribution of colonoscopic findings was similar for both groups.
Discussion
In our prospective study with comparable adherence and quality of colonoscopy, prevalence, and pathology of adenomas were similar in blacks and whites. Lieberman et al 1 reported that blacks were more likely to have large adenomas than were whites, with an overall difference of 0.9%, whereas Schroy et al 2 reported a 1.8% higher rate of advanced adenomas in whites compared with blacks. Neither study reported adherence rates. In our study, adherence to screening colonoscopy and polyp pathology were equivalent in both groups. Our study's strengths are its prospective design with both groups from the same population, standardized colonoscopies performed by a limited number of gastroenterologists, and all pathology reviewed by a single pathologist. With PN, equal adherence to screening colonoscopy allowed us to assess pathology differences without the bias of variability in adherence between groups.
Because this is a single-center study with a specific population, it lacks external validity. The sample size for completed colonoscopy was small. The larger study was powered to detect differences between colonoscopy and fecal occult blood test; the LSU part was to provide point estimates and confidence intervals for a larger clinical trial. Another limitation is selection bias with patients who were willing to participate in a clinical trial. In summary, our study facilitated comparable adherence to equal high-quality screening colonoscopy. We demonstrated that the prevalence and pathology of adenomas were similar in blacks and whites. Our study suggests that the higher reported incidence and mortality from CRC in blacks may be a function of access to colonoscopy as opposed to biology, and that equal access and high-quality colonoscopy may help eliminate racial disparities. A more definitive answer will require a large prospective study with sufficient power. 
